BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37877291)

  • 1. Keto-bridged dual triazole-linked benzenesulfonamides as potent carbonic anhydrase and cathepsin B inhibitors.
    Vats L; Arya P; Kumar R; Giovannuzzi S; Raghav N; Supuran CT; Sharma PK
    Future Med Chem; 2023 Oct; 15(20):1843-1863. PubMed ID: 37877291
    [No Abstract]   [Full Text] [Related]  

  • 2. Potent inhibitors of tumor associated carbonic anhydrases endowed with cathepsin B inhibition.
    Kumar A; Arya P; Sharma V; Giovannuzzi S; Raghav N; Supuran CT; Sharma PK
    Arch Pharm (Weinheim); 2023 Nov; 356(11):e2300349. PubMed ID: 37704930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors.
    Buza A; Türkeş C; Arslan M; Demir Y; Dincer B; Nixha AR; Beydemir Ş
    Int J Biol Macromol; 2023 Jun; 239():124232. PubMed ID: 37001773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and in silico insights of novel 1,2,3-triazole benzenesulfonamide derivatives as potential carbonic anhydrase IX and XII inhibitors with promising anticancer activity.
    Abdelhakeem MM; Morcoss MM; Hanna DA; Lamie PF
    Bioorg Chem; 2024 Mar; 144():107154. PubMed ID: 38309003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continued exploration and tail approach synthesis of benzenesulfonamides containing triazole and dual triazole moieties as carbonic anhydrase I, II, IV and IX inhibitors.
    Vats L; Kumar R; Bua S; Nocentini A; Gratteri P; Supuran CT; Sharma PK
    Eur J Med Chem; 2019 Dec; 183():111698. PubMed ID: 31539777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,2,3-Triazole-based esters and carboxylic acids as nonclassical carbonic anhydrase inhibitors capable of cathepsin B inhibition.
    Siwach K; Rani M; Vats L; Giovannuzzi S; Paul AK; Brahma M; Kumari N; Maruthi M; Raghav N; Supuran CT; Sharma PK
    Arch Pharm (Weinheim); 2024 Mar; 357(3):e2300372. PubMed ID: 38012535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors.
    El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Alanazi MM; El-Gendy MA; Ahmed HEA; Supuran CT
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):733-743. PubMed ID: 32189526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of 1,2,3-triazole linked benzenesulfonamide derivatives as isoform selective inhibitors of human carbonic anhydrase.
    Kakakhan C; Türkeş C; Güleç Ö; Demir Y; Arslan M; Özkemahlı G; Beydemir Ş
    Bioorg Med Chem; 2023 Jan; 77():117111. PubMed ID: 36463726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors.
    Said MA; Eldehna WM; Nocentini A; Bonardi A; Fahim SH; Bua S; Soliman DH; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT
    Eur J Med Chem; 2020 Jan; 185():111843. PubMed ID: 31718943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tail approach synthesis of triazolylthiazolotriazole bearing benzenesulfonamides as carbonic anhydrase inhibitors capable of inducing apoptosis.
    Vats L; Siwach K; Angeli A; Bikal P; Bhardwaj JK; Supuran CT; Sharma PK
    Arch Pharm (Weinheim); 2023 Feb; 356(2):e2200439. PubMed ID: 36344431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring novel anticancer pyrazole benzenesulfonamides featuring tail approach strategy as carbonic anhydrase inhibitors.
    Ahmed RF; Mahmoud WR; Abdelgawad NM; Fouad MA; Said MF
    Eur J Med Chem; 2023 Dec; 261():115805. PubMed ID: 37748386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and carbonic anhydrase inhibition studies of sulfonamide based indole-1,2,3-triazole chalcone hybrids.
    Singh P; Swain B; Thacker PS; Sigalapalli DK; Purnachander Yadav P; Angeli A; Supuran CT; Arifuddin M
    Bioorg Chem; 2020 Jun; 99():103839. PubMed ID: 32289586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of coumarin linked 1,2,4-oxadiazoles as selective carbonic anhydrase IX and XII inhibitors.
    Thacker PS; Angeli A; Argulwar OS; Tiwari PL; Arifuddin M; Supuran CT
    Bioorg Chem; 2020 May; 98():103739. PubMed ID: 32193032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of some coumarin hybrids as selective carbonic anhydrase IX and XII inhibitors.
    Thacker PS; Sridhar Goud N; Argulwar OS; Soman J; Angeli A; Alvala M; Arifuddin M; Supuran CT
    Bioorg Chem; 2020 Nov; 104():104272. PubMed ID: 32961467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation on Hydrazonobenzenesulfonamides as Human Carbonic Anhydrase I, II, IX and XII Inhibitors.
    Moi D; Vittorio S; Angeli A; Balboni G; Supuran CT; Onnis V
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzenesulfonamide bearing 1,2,4-triazole scaffolds as potent inhibitors of tumor associated carbonic anhydrase isoforms hCA IX and hCA XII.
    SitaRam ; Celik G; Khloya P; Vullo D; Supuran CT; Sharma PK
    Bioorg Med Chem; 2014 Mar; 22(6):1873-82. PubMed ID: 24560737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment.
    El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Almehizia AA; Alanazi MM; Hefnawy MM; Supuran CT
    Eur J Med Chem; 2019 Nov; 181():111573. PubMed ID: 31394463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel triazole-sulfonamide bearing pyrimidine moieties with carbonic anhydrase inhibitory action: Design, synthesis, computational and enzyme inhibition studies.
    Manzoor S; Petreni A; Raza MK; Supuran CT; Hoda N
    Bioorg Med Chem Lett; 2021 Sep; 48():128249. PubMed ID: 34237441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of 2-phenylquinoline-4-carboxamide linked benzene sulfonamide derivatives as isoform selective inhibitors of transmembrane human carbonic anhydrases.
    Swain B; Sahoo SK; Singh P; Angeli A; Yaddanapudi VM; Supuran CT; Arifuddin M
    Eur J Med Chem; 2022 Apr; 234():114247. PubMed ID: 35305463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.